Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma

Arighno Das, Ahmed Gabr, Daniel P. O'Brian, Ahsun Riaz, Kush Desai, Bartley Thornburg, Joseph R. Kallini, Samdeep Mouli, Robert J. Lewandowski, Riad Salem*

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

Health-related quality of life has become an important aspect in oncologic decision making. Recent data suggest that Health-Related Quality of Life (HRQoL) measurements can play an important prognostic role in patients with hepatocellular carcinoma (HCC). Locoregional therapies (LRTs) such as radiofrequency ablation, transarterial chemoembolization, and radioembolization (TARE) are important parts of HCC management. Results demonstrated that radiofrequency ablation treatment results in improving HRQoL compared to surgery for up to 3 years after treatment. Between TARE and transarterial chemoembolization, TARE provides the most benefit in terms of HRQoL. This systematic review investigated contemporary data surrounding HRQoL in patients undergoing LRTs and its impact on clinical decision making.

Original languageEnglish (US)
Pages (from-to)1924-1933.e2
JournalJournal of Vascular and Interventional Radiology
Volume30
Issue number12
DOIs
StatePublished - Dec 2019

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma'. Together they form a unique fingerprint.

  • Cite this